Motivations and Strategies for Vaccinations: A Public Health Perspective

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".

Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 1471

Special Issue Editors


E-Mail Website
Guest Editor
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, via Forlanini 2, 27100 Pavia, Italy
Interests: My research activity focuses on Vaccinations and Vaccine Preventable-Diseases, from the implementation and assessment of vaccination programs to the determinants of vaccine hesitancy (both among the general population and healthcare workers)

E-Mail Website
Guest Editor
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy
Interests: health systems; vaccines

Special Issue Information

Dear Colleagues,

The role and importance of vaccinations in reducing morbidity and mortality due to infectious diseases has been well established since their discovery, and they remain one of the greatest achievements in public health. However, over the past few decades, there has been a worrisome decrease in public trust towards vaccinations and an increase in vaccine hesitancy, leading to reduced vaccination coverage and the re-emergence of vaccine-preventable disease outbreaks. 

Different countries have responded to this trend in various ways, with some introducing or modifying previous vaccination mandates, while others have implemented communication campaigns on the importance of vaccinations. However, vaccination policies should be developed according to the local epidemiological situation and cultural context, targeting specific populations such as infants, adolescents, adults, the elderly, at-risk populations, and healthcare workers, and may be updated or modified according to new emerging threats.

Public health plays a crucial role in translating policies into effective practices. In addition, the understanding and acceptance of vaccines by the population are also essential to the success of vaccination policies and practices, and effective communication campaigns should be a priority for public health.

We are pleased to invite you to submit an article to this Special Issue about research in the field of vaccination strategies, campaigns, and their implementation in different contexts (including studies on COVID-19) as an essential component in achieving and maintaining optimal vaccination coverage, and therefore reducing the burden of vaccine-preventable diseases worldwide.

This Special Issue encourages the submission of original articles, comprehensive review, systematic reviews, meta-analyses, short communications, and other types of articles that can improve our knowledge on vaccination policies, practices, and related topics.

We look forward to receiving your contributions.

Dr. Giulia Dallagiacoma
Dr. Leandro Gentile
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccination
  • vaccines
  • policies
  • immunization
  • public health
  • vaccine-preventable diseases
  • vaccine hesitancy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 730 KiB  
Article
Vitamin D Supplementation and Prior Oral Poliovirus Vaccination Decrease Odds of COVID-19 Outcomes among Adults Recently Inoculated with Inactivated Poliovirus Vaccine
by Brittany A. Comunale, Yea-Jen Hsu, Robin J. Larson, Aditi Singh, Erin Jackson-Ward and Lilly D. Engineer
Vaccines 2024, 12(2), 121; https://doi.org/10.3390/vaccines12020121 - 24 Jan 2024
Viewed by 1273
Abstract
Background: Structural and functional commonalities between poliovirus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suggest that poliovirus inoculation may induce antibodies that mitigate the coronavirus disease (COVID-19). No known studies have evaluated COVID-19 risk factors in adults recently vaccinated against poliovirus. Study [...] Read more.
Background: Structural and functional commonalities between poliovirus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suggest that poliovirus inoculation may induce antibodies that mitigate the coronavirus disease (COVID-19). No known studies have evaluated COVID-19 risk factors in adults recently vaccinated against poliovirus. Study Objective: Among adults with no history of COVID-19 infection or vaccination, who recently received an inactivated poliovirus vaccine (IPV), we sought to determine which biological factors and social determinants of health (SDOH) may be associated with (1) testing positive for SARS-CoV-2, (2) experiencing COVID-19 symptoms, and (3) a longer duration of COVID-19 symptoms. Methods: The influence of biological factors and SDOH on SARS-CoV-2 infection and COVID-19 symptoms were evaluated among 282 adults recently inoculated with IPV. Participant-reported surveys were analyzed over 12 months post-enrollment. Bivariate and multivariate linear and logistic regression models identified associations between variables and COVID-19 outcomes. Results: Adjusting for COVID-19 vaccinations, variants, and other SDOH, secondary analyses revealed that underlying conditions, employment, vitamin D, education, and the oral poliovirus vaccination (OPV) were associated with COVID-19 outcomes. The odds of testing positive for SARS-CoV-2 and experiencing symptoms were significantly reduced among participants who took vitamin D (OR 0.12 and OR 0.09, respectively). Unemployed or part-time working participants were 72% less likely to test positive compared with full-time workers. No prior dose of OPV was one of the strongest predictors of SARS-CoV-2 infection (OR 4.36) and COVID-19 symptoms (OR 6.95). Conclusions: Findings suggest that prophylactic measures and mucosal immunity may mitigate the risk and severity of COVID-19 outcomes. Larger-scale studies may inform future policies. Full article
Show Figures

Figure 1

Back to TopTop